- New ETFs
- Bond ETFs
- Currency ETFs
- Emerging Market ETFs
- Commodity ETFs
- Broad U.S. Equity ETFs
- Sector ETFs
- Specialty ETFs
JPMorgan Upgrades Ariad Pharmaceuticals, Inc. To Overweight
Recent Articles by Benzinga Staff
- TheStreet.com (TSCM) Gains Nasdaq Listing Compliance
- Drake Energy Surges On Gas Estimate
- Who Dat Commodity 2/8/10 (UNG, SLV)
- China BAK, Conn's Are Early Winners
- Three Banks With Rising Shares, Big Dividends (NYB, UBSI, DCOM)
Analyst Color
- Prosperity Bancsahres, Inc. (PRSP) Maintains A Sector Perform Rating
- Post Properties, Inc.’s (PPS) Fourth-Quarter Review
- Camden Property Trust’s (CPT) Maintains A Sector Perform Rating
- Standpoint Initiates Coverage Of City Holding Co. (CHCO)
- FBR Gets Market Perform On SAP
Upgrades
- Standpoint Initiates Coverage Of City Holding Co. (CHCO)
- FBR Gets Market Perform On SAP
- Morgan Stanley Ups Rockwell To Equal Weight
- Spectra Energy Corp. (SE) Upgraded To An Outperform Rating
- Sierra Wireless, Inc. (SWIR) Upgraded To An Outperform Rating
Price Target
- FBR Gets Market Perform On SAP
- Morgan Stanley Ups Rockwell To Equal Weight
- Ritchie Bros. Auctioneers’ (RBA) Price Target Lowered
- Harman International Industries, Inc. (HAR) Price Target Raised
- SRX FQ2 Beats Marginally, Services Segment Robust, Losses At ERA
Analyst Ratings
Posted on 11/09/09 at 6:59am by Benzinga Staff
JPMorgan upgrades Ariad Pharmaceuticals, Inc. (Nasdaq: ARIA) to Overweight. The JPMorgan analyst raised ARIA price target to $6, Ariad closed just above $2 on Friday.
On JPMorgan's upgrade, Ariad Pharmaceuticals is trading up in the pre-market. The JPMorgan analyst raised his price target ahead of Ariad'spivotal late-stage data on sarcoma drug.
Bookmark/Search this post with:
Related Articles
Today's Trading Ideas
Featured Articles
Related News from the Stock Market
- Benzinga’s Top Pre- Market Losers (ASBC, MNKD, HOGS, AIXG, ARIA, ICXT)
- Barclays Continue With Their Overweight Call For ARIAD Pharmaceuticals (ARIA)
- Benzinga’s Top Pre- Market Gainers (ZILG, YONG, GERN, ARIA, XLNX)
- Benzinga's Updates (FUQI, ARIA, RCKY, STAA)
- Varian Medical Systems Selected for New Proton Therapy Center in Sweden
There are 0 comments
Please note that comments may take up to one hour before they get published on the site. Please check back later to see your comments.
Post new comment
Receive Benzinga's Best 2010 Stock Idea!
